Self-reactive T cells and degeneracy of T cell recognition: Evolving concepts - From sequence homology to shape mimicry and TCR flexibility

Journal of Autoimmunity

Volumn 16, Issue 3, 2001, Pages 201-209

  Maverakis, Emanual ^a   Van Den Elzen, Peter ^a   Sercarz, Eli E ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Autoimmunity; Degeneracy; Driver clones; Molecular mimicry; Self reactivity; TCR; Tolerance

Indexed keywords

AUTOANTIGEN; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANTIGEN RECOGNITION; AUTOIMMUNITY; CONFERENCE PAPER; CROSS REACTION; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; MOLECULAR MIMICRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE RECEPTOR GENE;

EID: 0034979180     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.2000.0493     Document Type: Conference Paper

References (97)

1. Immunological focusing by the mouse major histocompatibility complex: Mouse strains confronted with distantly related lysozymes confine their attention to very few epitopes
2. Antigen recognition by H-2-restricted T cells. II. A tryptic ovalbumin peptide that substitutes for processed antigen
3. The choice of T-cell epitopes utilized on a protein antigen depends on multiple factors distant from, as well as at the determinant site
4. Mechanisms influencing the immunodominance of T cell determinants
5. Dominance and crypticity of T cell antigenic determinants
6. A limited region within hen egg-white lysozyme serves as the focus for a diversity of T cell clones
7. Distinct recognition phenotypes exist for T cell clones specific for small peptide regions of proteins. Implications for the mechanisms underlying major histocompatibility complex-restricted antigen recognition and clonal deletion models of immune response gene defects
8. T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage
9. Public and private V beta T cell receptor repertoires against hen egg white lysozyme (HEL) in non-transgenic versus HEL transgenic mice
10. T cell determinant structure: Cores and determinant envelopes in three mouse major histocompatibility complex haplotypes
11. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: Mechanism for autoimmunity
12. Biological significance of alloreactivity: T cells stimulated by Sendai virus-coated syngeneic cells specifically lyse allogeneic target cells
13. Killer cells reactive to altered-self antigens can also be alloreactive
14. Alloreactivity of an antigen-specific T-cell clone
15. High frequency and non-random distribution of alloreactivity in T cell clones selected for recognition of foreign antigen in association with self class II molecules
16. A single T cell receptor recognizes structurally distinct MHC/peptide complexes with high specificity
17. T cell responses to myelin basic protein in experimental autoimmune encephalomyelitis-resistant BALB/c mice
18. Experimental autoimmune encephalomyelitis-resistant mice have highly encephalitogenic myelin basic protein (MBP)-specific T cell clones that recognize a MBP peptide with high affinity for MHC class II
19. A combination of adoptive transfer and antigenic challenge induces consistent murine experimental autoimmune encephalomyelitis in C57BL/6 mice and other reputed resistant strains
20. How some T cells escape tolerance induction
21. Immunogenicity of self antigens is unrelated to MHC-binding affinity: T-cell determinant structure of golli-MBP in the BALB/c mouse
22. Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease
23. Assembly, transport, and function of MHC class II molecules
24. How MHC class II molecules acquire peptide cargo: Biosynthesis and trafficking through the endocytic pathway
25. MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation
26. Antigen processing differences among APC
27. Hindrance of binding to class II major histocompatibility complex molecules by a single amino acid residue contiguous to a determinant leads to crypticity of the determinant as well as lack of response to the protein antigen
28. Modulation of the immunogenicity of antigenic determinants by their flanking residues
29. Fas ligand-induced apoptosis as a mechanism of immune privilege
30. Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells
31. Thymocytes express the golli products of the myelin basic protein gene and levels of expression are stage dependent
32. The human myelin basic protein gene is included within a 179-kilobase transcription unit: Expression in the immune and central nervous systems
33. T cell receptor complementarity determining region 3 length analysis reveals the absence of a characteristic public T cell repertoire in neonatal tolerance. The response in the 'tolerant' mouse within the residual repertoire is quantitatively similar but qualitatively different
34. Tolerance to a self-protein involves its immunodominant but does not involve its subdominant determinants
35. T-cell responses to myelin basic protein in normal and MBP-deficient mice
36. Endogenous myelin basic protein inactivates the high avidity T cell repertoire
37. Differential tolerance is induced in T cells recognizing distinct epitopes of myelin basic protein
38. Molecular mimicry in virus infection: Crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments
39. Virus-induced autoimmunity: Monoclonal antibodies that react with endocrine tissues
40. Monocloal antibody against human T cell leukemia virus p19 defines a human thymic epithelial antigen acquired during ontogeny
41. Coxsackievirus B-3 myocarditis in Balb/c mice. Evidence for autoimmunity to myocyte antigens
42. Sequence homology between certain viral proteins and proteins related to encephalomyelitis and neuritis
43. Molecular mimicry between uveitopathogenic site of retinal S-antigen and Escherichia coli protein: Induction of experimental autoimmune uveitis and lymphocyte cross-reaction
44. Cutting edge: Introduction of an endopeptidase cleavage motif into a determinant flanking region of hen egg lysozyme results in enhanced T cell determinant display
45. A polyalanine peptide with only five native myelin basic protein residues induces autoimmune encephalomyelitis
46. Structure of the human class I histocompatibility antigen, HLA-A2
47. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation
48. Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb
49. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide
50. Specific T cell recognition of minimally homologous peptides: Evidence for multiple endogenous ligands
51. Major histocompatibility complex binding affinity of an antigenic determinant is crucial for the differential secretion of interleukin 4/5 or interferon gamma by T cells
52. Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein
53. The CD1 system: Antigen-presenting molecules for T cell recognition of lipids and glycolipids
54. Immunogenicity. I. Use of peptide libraries to identify epitopes that activate clonotypic CD4+ T cells and induce T cell responses to native peptide ligands
55. A very high level of crossreactivity is an essential feature of the T-cell receptor
56. Degenerate recognition of a dissimilar antigenic peptide by myelin basic protein-reactive T cells. Implications for thymic education and autoimmunity
57. Autoimmune T cells: Immune recognition of normal and variant peptide epitopes and peptide-based therapy
58. Subjugation of dominant immunogenic determinants within a chimeric peptide
59. Molecular basis for recognition of an arthritic peptide and a foreign epitope on distinct MHC molecules by a single TCR
60. Molecular basis for the recognition of two structurally different major histocompatibility complex/peptide complexes by a single T-cell receptor
61. Intramolecular mimicry. Identification and analysis of two cross-reactive T cell epitopes within a single protein
62. Recognition of multiple peptide cores by a single T cell receptor
63. Highly cross-reactive T cell responses to myelin basic protein epitopes reveal a nonpredictable form of TCR degeneracy
64. Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone
65. Induction of Th1 and Th2 CD4+ T cell responses: The alternative approaches
66. Selective expansion of cross-reactive CD8(+) memory T cells by viral variants
67. Peptide-independent recognition by alloreactive cytotoxic T lymphocytes (CTL)
68. Analogs that compete for antigen binding to an arsonate-reactive T-cell clone inhibit the functional response to arsonate
69. Essential flexibility in the T-cell recognition of antigen
70. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand
71. Altered peptide ligand-induced partial T cell activation: Molecular mechanisms and role in T cell biology
72. Kinetics of T-cell receptor binding to peptide/I-Ek complexes: Correlation of the dissociation rate with T-cell responsiveness
73. A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists
74. High- and low-potency ligands with similar affinities for the TCR: The importance of kinetics in TCR signaling
75. Conversion of a T cell antonist into an agonist by repairing a defect in the TCR/peptide/MHC interface. Implications for TCR signaling
76. Peptide antagonism and T cell receptor interactions with peptide-MHC complexes
77. Structure, specificity and CDR mobility of a class II restricted single-chain T-cell receptor
78. Similar antigenic surfaces, rather than sequence homology, dictate T-cell epitope molecular mimicry
79. Predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homology
80. Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease
81. Organ-specific autoimmunity
82. Epitope spreading leads to myelin-specific autoimmune responses to SJL mice chronically infected with Theiler's virus
83. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading
84. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen
85. Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen
86. Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology
87. Molecular mimicry by herpes simplex virus-type 1: Autoimmune disease after viral infection
88. Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein
89. T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis
90. The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen-induced autoimmune disease
91. Regulatory T cells in autoimmunity
92. In vivo antagonism of a T cell response by an endogenously expressed ligand
93. Resistance to herpes stromal keratitis conferred by an IgG2a-derived peptide
94. Homeostasis and self-tolerance in the immune system: Turning lymphocytes off
95. Residual public repertoires to self
96. T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis
97. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments